iData Research Unveils European Dental Bone Graft Substitutes Market Insights

CANADA: iData Research, a global consulting and market research firm, has released exclusive research spotlighting the European Market for Dental Bone Graft Substitutes and Other Biomaterials. This comprehensive research offers invaluable insights into market trends, developments, and competitive dynamics that are shaping the landscape.

Driving Expansion: Dental Implant Procedures

The expansion of the Dental Bone Graft Substitutes (DBGS) and biomaterials market is spurred by the consistent demand for dental implant procedures. While the dental implant market holds a more advanced position in Europe, the broader adoption of dental grafts and biomaterials is on the rise. This momentum is fuelled by advancements in dental implantology and innovative treatment approaches.

According to iData’s 2023 European Dental Bone Graft Substitutes Suite of Market Reports, the overall market’s value surpassed €319.3 million in 2022. This value is projected to witness steady growth, reaching over €411.6 million by 2029, propelled by a cumulative average growth rate (CAGR) of 3.7%. 

The market’s sustained growth is attributed to demographic trends, educational and technological advancements, as well as strategic partnerships between dental companies and biomaterial manufacturers.

Dental Biomaterials Market Set to Achieve $15.8 Billion by 2030

In-Depth Market Insights

iData’s comprehensive report suite offers a deep dive into various facets of the market, encompassing unit sales, average selling prices, market drivers and limiters, competitive market share analysis, and other pertinent information. 

The report’s extensive analysis is spread across 10 countries, including Germany, France, United Kingdom, Italy, Spain, Benelux, Scandinavia, Austria, Switzerland, and Portugal. It covers an array of markets, including Dental bone graft substitutes (DBGSs), dental growth factors, dental barrier membranes (DBMs), local antimicrobial periodontal treatment, and dental soft tissue regeneration.

Introducing vallos, Geistlich’s first demineralized allograft

Dominant Players and Partnerships

In 2022, Geistlich emerged as a leading player in the European dental bone graft substitute market. Its dominance can be attributed to its strong presence in the xenograft segment, securing over half of the total market value in this category. 

botiss biomaterials, backed by a strategic partnership with the Straumann Group, held a significant portion of the DBGS and biomaterials market. Straumann Group’s robust standing in the dental implant market complemented botiss’ position in the DBGS market. 

ZimVie secured a prominent spot, driven by its influence across various segments including bone graft substitutes, dental membranes, and dental soft tissue regeneration.

ZimVie Releases the RegenerOss CC Allograft and RegenerOss Bone Graft Plug

Insights and Future Projections

iData’s report addresses key questions surrounding the market’s size, growth trajectory, competitive landscape, and trends. It provides a comprehensive outlook on the future trajectory of the DBGS market, considering emerging technologies, demographic shifts, and healthcare trends that might influence market dynamics.

iData Research is an influential international consulting and market research firm, empowering informed strategic decisions in the medical device, dental, and pharmaceutical industries.

Click for more information about the iData Research report.